Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

GBT Announces Participation at Upcoming Investor Conferences in March


Posted on: 05 Mar 18

SOUTH SAN FRANCISCO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the following investor conferences in March 2018:

  • Cowen and Company 38th Annual Health Care Conference in Boston on March 12 at 11:20 a.m. Eastern Time (ET);
  • 28th Annual Oppenheimer Healthcare Conference in New York City on March 20 at 10:55 a.m. ET; and
  • 17th Annual Needham Healthcare Conference in New York City on March 27 at 11:30 a.m. ET.

The presentations will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About GBT
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:
Myesha Lacy (investors)
GBT
650-351-4730
investor@gbt.com 

Julie Normart (media)
W2Opure
415-946-1087
media@gbt.com

GlobeNewswire
globenewswire.com

Last updated on: 06/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.